Posts Tagged 'Brilinta'

Good News for AZ’s Brilinta; Other Blood Thinners Still Struggle

Pharmaceutical giant AstraZeneca has been given the go-ahead to market a new, 60-milligram dose of their blood thinner Brilinta for longer-term use in patients who have suffered heart attacks. According to Reuters, the U.S. Food and Drug Administration (FDA) approved the new dose for use along with aspirin at any time after a heart attack. Brilinta, an antiplatelet drug used to prevent blood clots, was previously available only at a higher dosage, and ...

continue reading...

New AstraZeneca Study Shows Mixed Results for Blood-Thinning Drug

The results of AstraZeneca’s recent trials for its blood-thinning drug Brilinta show a decreased risk of post–heart attack heart problems but an increased risk of major bleeding after using the drug. The pharmaceutical company’s large-scale PEGASUS-TIMI 54 trial included 21,000 patients who had suffered at least one heart attack in the past three years. Patients received either a high dose of Brilinta, a low dose of Brilinta, or a placebo drug. All patients ...

continue reading...